Skip to main content

UPSHER-SMITH 0226 20 mg Pill: yellow, capsule/oblong, 14mm

The pill with imprint UPSHER-SMITH 0226 20 mg (Yellow, Capsule/Oblong, 14mm) has been identified as Morphine Sulfate Extended-Release 20 mg and is used for Chronic Pain, Neonatal Abstinence Syndrome, and Pain. It belongs to the drug class Opioids (narcotic analgesics) and is classified as CSA Schedule 2 (High potential for abuse).

Images for UPSHER-SMITH 0226 20 mg

Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg Front
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg Back
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg

Morphine Sulfate Extended-Release

Imprint
UPSHER-SMITH 0226 20 mg
Strength
20 mg
Color
Yellow
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Upsher-Smith Laboratories, Inc.
National Drug Code (NDC)
00832-0226
Inactive Ingredients
microcrystalline cellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 4000, diethyl phthalate, magnesium silicate, titanium dioxide, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.